Chemaly, Alicia
Arnould, Louis
Seydou, Alassane
Gabrielle, Pierre-Henry
Baudin, Florian
Acar, Niyazi
Creuzot-Garcher, Catherine
Article History
Received: 16 February 2021
Accepted: 11 March 2021
First Online: 23 March 2021
Declarations
:
: The study has been approved by the Ethical Committee of the 3 Cities Study and registered as 2009-A00448–49. Written informed consent was obtained from the participants or from legal guardians of the participants if they are blind and the study followed the tenets of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no non-financial competing interests.Disclosure: AC, None; LA, None; AS, None; PHG, None; FB, Novartis (C), Thea (C); NA, None; CCG, Allergan (C), Bayer (C), Horus (C), Novartis (C), Roche (C), Théa (C).